Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
23andMe Holding Co.

23andMe Holding Co. (MEUSW) Stock Overview

Explore 23andMe Holding Co.’s financial performance, market position, analyst ratings, and future outlook.

MEUSW●NASDAQ
HealthcareMedical - Diagnostics & Research
$1.38
$0.13(8.61%)
U.S. Market opens in 13h 58m

23andMe Holding Co. (MEUSW)

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio-0.13
EPS (TTM)N/A
ROE-42.03%
Fundamental Analysis

AI Price Forecasts

1 Month$1.39
3 Months$0.60
1 Year Target$0.00

MEUSW Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of 23andMe Holding Co. (NASDAQ: MEUSW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, 23andMe Holding Co.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MEUSW on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind 23andMe Holding Co.'s NASDAQ-traded stock include a P/E ratio of -0.13 and a market capitalization of 0. Combined with our AI analysis, these give both institutional and retail investors a clear view of MEUSW on the NASDAQ.

Price Performance (NASDAQ: MEUSW)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
-57.54%
All-Time (Max) Change
-57.54%

Contact Information

https://www.23andme.org
800 239 5230
223 N. Mathilda Ave., Sunnyvale, CA, 94086

Company Facts

IPO DateJun 17, 2021
CountryUS

Frequently Asked Questions